You M - Search Results

1

Targeting Glutamine Metabolism to Enhance Immunoprevention of EGFR-Driven Lung Cancer.

Huang M, Xiong D, Pan J, Zhang Q, Sei S, Shoemaker RH, Lubet RA, Montuenga LM, Wang Y, Slusher BS, You M. Huang M, et al. Among authors: you m. Adv Sci (Weinh). 2022 Sep;9(26):e2105885. doi: 10.1002/advs.202105885. Epub 2022 Jul 21. Adv Sci (Weinh). 2022. PMID: 35861366 Free PMC article.

2

Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.

McDoniels-Silvers AL, Stoner GD, Lubet RA, You M. McDoniels-Silvers AL, et al. Among authors: you m. Neoplasia. 2002 Mar-Apr;4(2):141-50. doi: 10.1038/sj.neo.7900217. Neoplasia. 2002. PMID: 11896569 Free PMC article.

3

Differential gene expression in human lung adenocarcinomas and squamous cell carcinomas.

McDoniels-Silvers AL, Nimri CF, Stoner GD, Lubet RA, You M. McDoniels-Silvers AL, et al. Among authors: you m. Clin Cancer Res. 2002 Apr;8(4):1127-38. Clin Cancer Res. 2002. PMID: 11948124

4

p53 transgenic mice are highly susceptible to 1, 2-dimethylhydrazine-induced uterine sarcomas.

Zhang Z, Li J, Lantry LE, Wang Y, Wiseman RW, Lubet RA, You M. Zhang Z, et al. Among authors: you m. Cancer Res. 2002 Jun 1;62(11):3024-9. Cancer Res. 2002. PMID: 12036908

5

Differentially expressed genes associated with mouse lung tumor progression.

Yao R, Wang Y, Lubet RA, You M. Yao R, et al. Among authors: you m. Oncogene. 2002 Aug 22;21(37):5814-21. doi: 10.1038/sj.onc.1205422. Oncogene. 2002. PMID: 12173053

6

Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.

De Flora S, Balansky RM, D'Agostini F, Izzotti A, Camoirano A, Bennicelli C, Zhang Z, Wang Y, Lubet RA, You M. De Flora S, et al. Among authors: you m. Cancer Res. 2003 Feb 15;63(4):793-800. Cancer Res. 2003. PMID: 12591728

7

Differential gene expression in chemically induced mouse lung adenomas.

Yao R, Wang Y, Lubet RA, You M. Yao R, et al. Among authors: you m. Neoplasia. 2003 Jan-Feb;5(1):41-52. doi: 10.1016/s1476-5586(03)80016-7. Neoplasia. 2003. PMID: 12659669 Free PMC article.

8

Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.

Wang Y, Zhang Z, Kastens E, Lubet RA, You M. Wang Y, et al. Among authors: you m. Cancer Res. 2003 Aug 1;63(15):4389-95. Cancer Res. 2003. PMID: 12907609

9

Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.

Zhang Z, Wang Y, Lantry LE, Kastens E, Liu G, Hamilton AD, Sebti SM, Lubet RA, You M. Zhang Z, et al. Among authors: you m. Oncogene. 2003 Sep 18;22(40):6257-65. doi: 10.1038/sj.onc.1206630. Oncogene. 2003. PMID: 13679864

10

Molecular profiling of mouse lung tumors: association with tumor progression, lung development, and human lung adenocarcinomas.

Bonner AE, Lemon WJ, Devereux TR, Lubet RA, You M. Bonner AE, et al. Among authors: you m. Oncogene. 2004 Feb 5;23(5):1166-76. doi: 10.1038/sj.onc.1207234. Oncogene. 2004. PMID: 14647414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,976 results

Search Page

Filters